Skip to main content

Security report for amoena.com

Respecta · Healthcare · Finland

Medium risk. 4 critical or high findings in GDPR outside view and SSL/TLS.

Security score

63/100

Risk levelMedium

0–100, higher is better. How it is calculated

Respecta is a Finnish healthcare company specializing in post-operative care solutions for breast surgery patients. They provide a range of products including breast prostheses and bras, partnering with Amoena, a global leader in breast prosthetics. The website is well-structured, professionally designed, and targets patients and healthcare providers in Finland. Technically, the site uses modern tools such as Google Tag Manager, Usercentrics for consent management, and Leadoo chatbot for customer engagement. The site is mobile-optimized and accessible, with good SEO practices. Security-wise, the site uses HTTPS and consent mechanisms but lacks explicit security policies or incident response contacts. Overall, the website is trustworthy and compliant with GDPR, with clear contact information and privacy policies.

Scanned

NIS2 and GDPR posture

GDPR outside view
28/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      No HTTPS encryption

      GDPR requires appropriate security measures for personal data

      What to do: Implement SSL/TLS certificate for HTTPS

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      No HTTPS Encryption

      Website does not use HTTPS encryption, making all data transmission vulnerable to interception

      What to do: Implement SSL/TLS certificate and redirect all HTTP traffic to HTTPS

Need hands-on remediation? Email guard@offseq.com

Keep watching amoena.com

This scan found 15 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
80
Email security
85
DNS health
85
Network security
100
GDPR outside view
28
Average
63

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Respecta holds a strong position in the Finnish healthcare market for medical aids related to breast surgery recovery. Their partnership with Amoena enhances their product offering and market credibility. The business model focuses on providing specialized healthcare products and services, including consultations and educational events. The company targets breast surgery patients and healthcare organizations, leveraging digital tools for marketing and customer support. The presence of detailed privacy and cookie policies, along with transparent contact information, supports customer trust and regulatory compliance.

Security posture

The website demonstrates a moderate to good security posture with HTTPS enabled and use of a consent management platform. However, it lacks published security policies and incident response contacts, which are important for transparency and vulnerability management. No vulnerabilities or exposed sensitive data were detected in the HTML content. The use of third-party scripts is controlled via Google Tag Manager and Usercentrics, reducing risk. Recommendations include implementing additional HTTP security headers and publishing a security.txt file.

Recommendations

  1. Implement comprehensive HTTP security headers such as Content-Security-Policy, HSTS, X-Content-Type-Options, and X-Frame-Options.
  2. Publish a clear security policy and incident response contact information on the website.
  3. Add a security.txt file to facilitate vulnerability disclosure and improve transparency.
  4. Regularly audit third-party scripts and dependencies for vulnerabilities.
  5. Enhance monitoring and logging to detect and respond to security incidents promptly.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Respecta
Description
Respecta offers solutions for post-operative care for breast surgery patients, including initial care products, breast prostheses, and bras. They partner with Amoena, a global leader in breast surgery solutions and the first developer of silicone breast prostheses.
Key services
Post-operative breast care products, Breast prostheses, Medical aids and rehabilitation solutions, Consultations and educational events
Content quality
good
Branding
consistent

Technology

Stack
Google Tag Manager, Usercentrics Consent Management, Leadoo Chatbot, ReadSpeaker, jQuery (implied by adapter script), Flexslider
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
80/100
Good practices seen
  • Use of consent management platform (Usercentrics)
  • Google Tag Manager for controlled script loading
  • No exposed credentials or sensitive data in HTML

Analytics and tracking

Services
Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Marketing tools
Usercentrics Consent Management, Leadoo Chatbot
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website content is fully accessible and not blocked by WAF or security mechanisms.
  2. The site is focused on healthcare solutions for breast surgery patients, with a strong partnership with Amoena.
  3. Comprehensive privacy and cookie policies are present with a consent management platform in use.
  4. Contact information is clearly provided including phone numbers and emails.
  5. No explicit security policy or incident response contacts found.
  6. Use of modern marketing and analytics tools with consent mechanisms.
  7. No suspicious or malicious content detected.
  8. Good overall website quality and user experience.
Technical notes

Notes

The website uses a modern technology stack including Google Tag Manager, Usercentrics for GDPR-compliant consent management, and Leadoo chatbot for customer interaction. The presence of ReadSpeaker scripts indicates accessibility features for users with disabilities. The site appears to be custom-built or uses a less common CMS, as no popular CMS signatures were detected. Performance is moderate with room for optimization. The site is mobile-friendly and well-structured for SEO. Technical risks are minimal but could be reduced further by improving security headers and ensuring all third-party scripts are up to date.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with amoena.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review amoena.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.